Frontlight ResearchEarly access
Haemophilia trials in Netherlands
3 of 8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
- Where
- Amsterdam, Groningen, Utrecht
- Age
- 12 years and over
- People
- 360 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416604 · EU 2025-522435-33-00 - Phase 3Taking peopleA Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
- Where
- Utrecht
- Age
- 12 years and over
- People
- 138 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07416526 · EU 2025-522434-32-00 - Phase 4Taking peoplePharmacokinetic-guided dosing of emicizumab in congenital haemophilia A patients – The DosEmi study
- Where
- Amsterdam, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, 's-Gravenhage, Utrecht
- People
- 135
- Run by
- Universitair Medisch Centrum Utrecht
See details and how to joinNCT06320626 · EU 2024-515528-35-00